{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:33:44Z","timestamp":1792481624994,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,21]]},"DOI":"10.7759\/cureus.43867","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T17:38:46Z","timestamp":1692639526000},"source":"Crossref","is-referenced-by-count":5,"title":["The Controversies Surrounding Acne and Suicide: Essential Knowledge for Clinicians"],"prefix":"10.7759","author":[{"given":"Nihit","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayank","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Death rates due to suicide and homicide among persons aged 10-24. United States, 2000-2017. (2020). Accessed: August 13, 2023: https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db352.htm."},{"key":"ref2","unstructured":"ACCUTANE (isotretinoin capsules) Label. (2008). Accessed. August 19, 2023: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2008\/018662s059lbl.pdf."},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1177\/089719009901200502","article-title":"Roaccutane (isotretinoin) and the risk of suicide: case report and a review of the literature and pharmacovigilance reports","volume":"12","author":"Middelkoop T","year":"1999","unstructured":"Middelkoop T. Roaccutane (isotretinoin) and the risk of suicide: case report and a review of the literature and pharmacovigilance reports. Journal of Pharmacy Practice. 1999, 12:374-378.","journal-title":"Journal of Pharmacy Practice"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13462","article-title":"A global perspective on the epidemiology of acne","volume":"172 Suppl 1","author":"Tan JK","year":"2015","unstructured":"Tan JK, Bhate K. A global perspective on the epidemiology of acne. Br J Dermatol. 2015, 172 Suppl 1:3-12. 10.1111\/bjd.13462","journal-title":"Br J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12149","article-title":"Epidemiology of acne vulgaris","volume":"168","author":"Bhate K","year":"2013","unstructured":"Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013, 168:474-85. 10.1111\/bjd.12149","journal-title":"Br J Dermatol"},{"key":"ref6","unstructured":"Isotretinoin capsule information. (2021). Accessed. August 19, 2023: https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/isotretinoin-capsule-information."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c5812","article-title":"Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study","volume":"341","author":"Sundstr\u00f6m A","year":"2010","unstructured":"Sundstr\u00f6m A, Alfredsson L, Sj\u00f6lin-Forsberg G, Gerd\u00e9n B, Bergman U, Jokinen J. Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study. BMJ. 2010, 341:c5812. 10.1136\/bmj.c5812","journal-title":"BMJ"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.264","article-title":"Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population-based study","volume":"131","author":"Halvorsen JA","year":"2011","unstructured":"Halvorsen JA, Stern RS, Dalgard F, Thoresen M, Bjertness E, Lien L. Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population-based study. J Invest Dermatol. 2011, 131:363-70. 10.1038\/jid.2010.264","journal-title":"J Invest Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000026035","article-title":"The analysis of acne increasing suicide risk","volume":"100","author":"Xu S","year":"2021","unstructured":"Xu S, Zhu Y, Hu H, et al.. The analysis of acne increasing suicide risk. Medicine (Baltimore). 2021, 100:e26035. 10.1097\/MD.0000000000026035","journal-title":"Medicine (Baltimore)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2017.10.004","article-title":"How acne bumps cause the Blues: the influence of acne vulgaris on self-esteem","volume":"4","author":"Gallitano SM","year":"2018","unstructured":"Gallitano SM, Berson DS. How acne bumps cause the Blues: the influence of acne vulgaris on self-esteem. Int J Womens Dermatol. 2018, 4:12-7. 10.1016\/j.ijwd.2017.10.004","journal-title":"Int J Womens Dermatol"},{"key":"ref11","article-title":"iPLEDGE must abstain from abstinence","volume":"13","author":"Lowery K","year":"2020","unstructured":"Lowery K, Rosen T, Malek J. iPLEDGE must abstain from abstinence. J Clin Aesthet Dermatol. 2020, 13:54-6.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadr.2021.100230","article-title":"Isotretinoin and neuropsychiatric side effects: continued vigilance is needed","volume":"6","author":"Bremner JD","year":"2021","unstructured":"Bremner JD. Isotretinoin and neuropsychiatric side effects: continued vigilance is needed. J Affect Disord Rep. 2021, 6:100230. 10.1016\/j.jadr.2021.100230","journal-title":"J Affect Disord Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l7085","article-title":"Isotretinoin: experts convene to investigate new concerns over suicide risk","volume":"367","author":"Mahase E","year":"2019","unstructured":"Mahase E. Isotretinoin: experts convene to investigate new concerns over suicide risk. BMJ. 2019, 367:l7085. 10.1136\/bmj.l7085","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.1416","article-title":"Psychiatric adverse events in patients taking isotretinoin as reported in a food and Drug Administration database from 1997 to 2017","volume":"155","author":"Singer S","year":"2019","unstructured":"Singer S, Tkachenko E, Sharma P, Barbieri JS, Mostaghimi A. Psychiatric adverse events in patients taking isotretinoin as reported in a food and Drug Administration database from 1997 to 2017. JAMA Dermatol. 2019, 155:1162-6. 10.1001\/jamadermatol.2019.1416","journal-title":"JAMA Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.21049","article-title":"Isotretinoin and adverse neuropsychiatric outcomes: retrospective cohort study using routine data","volume":"187","author":"Paljarvi T","year":"2022","unstructured":"Paljarvi T, McPherson T, Luciano S, Herttua K, Fazel S. Isotretinoin and adverse neuropsychiatric outcomes: retrospective cohort study using routine data. Br J Dermatol. 2022, 187:64-72. 10.1111\/bjd.21049","journal-title":"Br J Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.01.107","article-title":"Psychiatric disorders and suicidal behavior in patients with acne prescribed oral antibiotics versus isotretinoin: analysis of a large commercial insurance claims database","volume":"85","author":"Ugonabo N","year":"2021","unstructured":"Ugonabo N, Love E, Wong PW, Rieder EA, Orlow SJ, Kim RH, Nagler AR. Psychiatric disorders and suicidal behavior in patients with acne prescribed oral antibiotics versus isotretinoin: analysis of a large commercial insurance claims database. J Am Acad Dermatol. 2021, 85:878-84. 10.1016\/j.jaad.2021.01.107","journal-title":"J Am Acad Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.11.055","article-title":"Evaluating the barriers to isotretinoin treatment for acne vulgaris in pediatric patients","volume":"85","author":"Shah N","year":"2021","unstructured":"Shah N, Smith E, Kirkorian AY. Evaluating the barriers to isotretinoin treatment for acne vulgaris in pediatric patients. J Am Acad Dermatol. 2021, 85:1597-9. 10.1016\/j.jaad.2020.11.055","journal-title":"J Am Acad Dermatol"},{"key":"ref18","unstructured":"Suicides linked to acne drug roaccutane as regulator reopens inquiry. The Guardian. (2019). Accessed. August 13, 2023: https:\/\/www.theguardian.com\/society\/2019\/dec\/27\/suicides-linked-to-acne-drug-roaccutane-as-regulator-reopens-inquiry."},{"key":"ref19","unstructured":"Report of the Commission on Human Medicines isotretinoin expert working group. (2023). Accessed. July 31, 2023: https:\/\/www.gov.uk\/government\/publications\/report-of-the-commission-on-human-medicines-isotretinoin-expert-working-group."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/1203475417719052","article-title":"Association of isotretinoin with depression and suicide: a review of current literature","volume":"22","author":"Oliveira JM","year":"2018","unstructured":"Oliveira JM, Sobreira G, Velosa J, Telles Correia D, Filipe P. Association of isotretinoin with depression and suicide: a review of current literature. J Cutan Med Surg. 2018, 22:58-64. 10.1177\/1203475417719052","journal-title":"J Cutan Med Surg"},{"key":"ref21","unstructured":"ClinCalc DrugStats Database. (2022). Accessed. August 13, 2023: https:\/\/clincalc.com\/DrugStats\/."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.136.10.1231","article-title":"Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide","volume":"136","author":"Jick SS","year":"2000","unstructured":"Jick SS, Kremers HM, Vasilakis-Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Arch Dermatol. 2000, 136:1231-6. 10.1001\/archderm.136.10.1231","journal-title":"Arch Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2019.10.006","article-title":"Acne and the lesbian, gay, bisexual, or transgender teenager","volume":"38","author":"Ragmanauskaite L","year":"2020","unstructured":"Ragmanauskaite L, Kahn B, Ly B, Yeung H. Acne and the lesbian, gay, bisexual, or transgender teenager. Dermatol Clin. 2020, 38:219-26. 10.1016\/j.det.2019.10.006","journal-title":"Dermatol Clin"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2005.05.008","article-title":"Acne, depression, and suicide","volume":"23","author":"Hull PR","year":"2005","unstructured":"Hull PR, D'Arcy C. Acne, depression, and suicide. Dermatol Clin. 2005, 23:665-74. 10.1016\/j.det.2005.05.008","journal-title":"Dermatol Clin"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/504279","article-title":"Female gender and acne disease are jointly and independently associated with the risk of major depression and suicide: a national population-based study","volume":"2014","author":"Yang YC","year":"2014","unstructured":"Yang YC, Tu HP, Hong CH, et al.. Female gender and acne disease are jointly and independently associated with the risk of major depression and suicide: a national population-based study. Biomed Res Int. 2014, 2014:504279. 10.1155\/2014\/504279","journal-title":"Biomed Res Int"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.12.028","article-title":"Isotretinoin treatment for acne and risk of depression: a systematic review and meta-analysis","volume":"76","author":"Huang YC","year":"2017","unstructured":"Huang YC, Cheng YC. Isotretinoin treatment for acne and risk of depression: a systematic review and meta-analysis. J Am Acad Dermatol. 2017, 76:1068-1076.e9. 10.1016\/j.jaad.2016.12.028","journal-title":"J Am Acad Dermatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2017.08.001","article-title":"Dermatologic conditions and risk of suicide: a case-control study","volume":"59","author":"Prabhakar D","year":"2018","unstructured":"Prabhakar D, Peterson EL, Hu Y, et al.. Dermatologic conditions and risk of suicide: a case-control study. Psychosomatics. 2018, 59:58-61. 10.1016\/j.psym.2017.08.001","journal-title":"Psychosomatics"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/ced.15039","article-title":"First use of the Adolescent Depression Rating Scale (ADRS) in the management of young people with severe acne treated with isotretinoin: a pilot study of an active monitoring of depressive disorders by dermatologists","volume":"47","author":"Hefez L","year":"2022","unstructured":"Hefez L, Micallef J, Revah-Levy A, Falissard B, Jouve E, Dreno B, Chosidow O. First use of the Adolescent Depression Rating Scale (ADRS) in the management of young people with severe acne treated with isotretinoin: a pilot study of an active monitoring of depressive disorders by dermatologists. Clin Exp Dermatol. 2022, 47:709-16. 10.1111\/ced.15039","journal-title":"Clin Exp Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/177839-the-controversies-surrounding-acne-and-suicide-essential-knowledge-for-clinicians","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:49:09Z","timestamp":1707508149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/177839-the-controversies-surrounding-acne-and-suicide-essential-knowledge-for-clinicians"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.43867","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,21]]}}}